Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
Mitchell
News Release
FDA Approval of Dsuvia: Why Now and What Might it Mean for Workers' Compensation?
The FDA recently approved a new opioid that is causing some concern.
Workers' Comp
Article
A Provider of Hope
Kids’ Chance Awareness Week is a great opportunity to support an organization so close to our hearts As the holiday season approaches, ma
Mitchell
News Release
Marijuana Legalization Gains Ground
The legalization of marijuana marched forward on Election Day, though it stubbed its toe in North Dakota.
Workers' Comp
Article
StateWatch: Winter 2018
Keep current with new legislation and its potential effect on your organization.
Workers' Comp
Article
The Art of Creating a Physician Peer Review Panel - Part 1
Creating a physician peer review panel is like solving a puzzle – it comes together only after reviewing the landscape, discerning what is importan
Workers' Comp
Blog
Navigating the Landscape of Drug Formularies and Prescribing and Treatment Guidelines
Over the course of the next several years we can expect more and more jurisdictions to move towards adoption of legislative and/or regulatory measures